PISANO, Calogera
 Distribuzione geografica
Continente #
NA - Nord America 6.766
AS - Asia 4.139
EU - Europa 3.575
SA - Sud America 740
AF - Africa 110
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 7
Totale 15.349
Nazione #
US - Stati Uniti d'America 6.595
SG - Singapore 1.592
RU - Federazione Russa 1.218
CN - Cina 1.058
IT - Italia 701
BR - Brasile 591
HK - Hong Kong 367
VN - Vietnam 332
FI - Finlandia 326
PL - Polonia 295
DE - Germania 273
BD - Bangladesh 221
FR - Francia 203
GB - Regno Unito 148
JP - Giappone 110
IE - Irlanda 97
KR - Corea 87
UA - Ucraina 86
IN - India 82
CA - Canada 72
AR - Argentina 44
RO - Romania 43
MX - Messico 41
SE - Svezia 40
TR - Turchia 39
NL - Olanda 38
IQ - Iraq 37
SA - Arabia Saudita 31
ID - Indonesia 25
ZA - Sudafrica 25
EC - Ecuador 24
PK - Pakistan 24
CO - Colombia 21
ES - Italia 20
VE - Venezuela 19
AT - Austria 17
BE - Belgio 17
UZ - Uzbekistan 17
CI - Costa d'Avorio 16
KE - Kenya 15
MA - Marocco 15
NP - Nepal 15
JM - Giamaica 13
MY - Malesia 12
PH - Filippine 12
PY - Paraguay 12
CL - Cile 11
AE - Emirati Arabi Uniti 10
CR - Costa Rica 10
EG - Egitto 10
JO - Giordania 9
AZ - Azerbaigian 8
IR - Iran 8
UY - Uruguay 8
DZ - Algeria 7
EU - Europa 7
TT - Trinidad e Tobago 7
AU - Australia 6
GR - Grecia 6
MT - Malta 6
TN - Tunisia 6
AL - Albania 5
BG - Bulgaria 5
HN - Honduras 5
PR - Porto Rico 5
BH - Bahrain 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
IL - Israele 4
LB - Libano 4
NG - Nigeria 4
PE - Perù 4
PS - Palestinian Territory 4
RS - Serbia 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
DK - Danimarca 3
ET - Etiopia 3
GE - Georgia 3
GY - Guiana 3
LT - Lituania 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BN - Brunei Darussalam 2
CY - Cipro 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MD - Moldavia 2
NI - Nicaragua 2
TG - Togo 2
Totale 15.328
Città #
Singapore 1.116
Ashburn 858
San Jose 623
Fairfield 537
Hong Kong 362
Chandler 349
Woodbridge 290
Zgierz 278
Council Bluffs 258
Houston 248
Wilmington 239
Seattle 232
Moscow 191
Cambridge 187
Hefei 181
Ann Arbor 172
Santa Clara 165
Beijing 144
Palermo 135
Lauterbourg 123
Los Angeles 113
Tokyo 108
Ho Chi Minh City 100
New York 99
Dallas 97
Dublin 97
Helsinki 84
Hanoi 83
Des Moines 82
Medford 82
Rome 68
Buffalo 66
São Paulo 55
Dearborn 54
Boardman 52
Chicago 51
Altamura 50
Princeton 50
Frankfurt am Main 44
Guangzhou 44
Nanjing 44
The Dalles 44
Milan 41
Jacksonville 37
Redondo Beach 36
San Diego 36
Nuremberg 35
Lawrence 34
Columbus 33
London 32
Phoenix 28
Piscataway 27
Shenyang 27
Atlanta 25
Riyadh 23
Montreal 20
Denver 19
Orem 19
Tulsa 19
Munich 17
Abidjan 16
Brussels 16
Changsha 16
Lappeenranta 16
Belo Horizonte 15
Bologna 15
Brooklyn 15
Chennai 15
Da Nang 15
Falls Church 15
Jinan 15
Mumbai 15
Rio de Janeiro 15
Tashkent 15
Haiphong 14
Nairobi 14
Nanchang 14
Paris 14
Salt Lake City 14
Seoul 14
Xi'an 14
Baghdad 13
Ningbo 13
Toronto 13
Ludwigshafen am Rhein 12
Tianjin 12
Curitiba 11
Hải Dương 11
Naples 11
Warsaw 11
Ankara 10
Hebei 10
Jiaxing 10
Johannesburg 10
Shanghai 10
Vienna 10
Zhengzhou 10
Amsterdam 9
Poplar 9
Porto Alegre 9
Totale 9.279
Nome #
Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals? 267
Can the TLR-4-Mediated Signaling Pathway Be a Key Inflammatory Promoter for Sporadic TAA? 267
A particular phenotype of ascending aorta aneurysms as precursor of type A aortic dissection 259
Are Endothelial Progenitor Cells the Real Solution for Cardiovascular Diseases? Focus on Controversies and Perspectives 256
THE ROLE OF INFLAMMATION IN TYPE A AORTIC DISSECTION: A PILOT STUDY 243
Histological and genetic studies in patients with bicuspid aortic valve and ascending aorta complications 241
OBTAINING MESENCHYMAL STEM CELLS FROM ADIPOSE TISSUE OR MURIN ORIGIN: EXPERIMENTAL STUDY. 240
Penn classification in acute aortic dissection patients 240
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial. 240
Deregulation of Notch1 pathway and circulating endothelial progenitor cell (EPC) number in patients with bicuspid aortic valve with and without ascending aorta aneurysm 239
Associations of rs3918242 and rs2285053 MMP-9 and MMP-2 polymorphisms with the risk, severity, and short- and long-term complications of degenerative mitral valve diseases: A 4.8-year prospective cohort study 237
Identification of Three Particular Morphological Phenotypes in Sporadic Thoracic Aortic Aneurysm: Phenotype III As Sporadic Thoracic Aortic Aneurysm biomarker in Aged Individuals 234
Is the mean blood leukocyte telomere length a predictor for sporadic thoracic aortic aneurysm? Data from a preliminary study 233
Cardiovascular disease in ageing: An overview on thoracic aortic aneurysm as an emerging inflammatory disease 232
Role of Matrix Metalloproteinases in complications of thoracic aortic aneurysm 223
A Typical Immune T/B Subset Profile Characterizes Bicuspid Aortic Valve: In an Old Status? 223
Coronary artery fistulas: symptoms may not correlate to size. An emblematic case and literature review 220
Early structural degeneration of Mitroflow aortic valve: Another issue in addition to the mismatch? 213
Ascending aorta phenotypic and genotypic changes in bicuspid aortic valve disease 211
Decellularized Saphena: Biologic Scaffold for 3D Cellular Growth 193
Impact of Prosthesis-Patient Mismatch after Mitral Valve Replacement 193
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study. 192
Role of TGF-β pathway polymorphisms in sporadic thoracic aortic aneurysm: rs900 TGF-β2 is a marker of differential gender susceptibility. 189
Valve prosthesis-patient mismatch: hemodynamic, echocardiographic and clinical consequences 186
Deregulation of TLR4 signaling pathway characterizes Bicuspid Aortic valve syndrome 184
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: The MITO-2 randomized phase III trial 182
Regulation of PDE5 expression in human aorta and thoracic aortic aneurysms 179
Is the sporadic thoracic aneurysm the result of inflammatory process 172
CAN THE AORTIC WALL COMMUNICATE WITH US? 171
Role of cachexia and fragility in the patient candidate for cardiac surgery 171
Focus on the unique mechanisms involved in thoracic aortic aneurysm formation in bicuspid aortic valve vs tricuspid aortic valve patients: clinical implications of a pilot study 169
Biomechanical properties and histomorphometric features of aortic tissue in patients with or without bicuspid aortic valve 166
Is the Serum N Terminal Pro-Brain Natriuretic Peptide the Best Candidate Biomarker for Long-term Prognosis in Patients with Prosthesis-patient Mismatch after Mitral Valve Replacement? 164
Vascular Aging effect on Medial aorta degeneration: focus on blood keukocyte telomere lenght in Hypertensive and old patients with sporadic thoracic aortic aneurysm 159
Can The Aortic Wall Comunicate With Us? 158
Diagnostic and Prognostic Relevance of Red Blood Cell Distribution Width for Vascular Aging and Cardiovascular Diseases 156
Red Blood Cell Distribution Width, Vascular Aging Biomarkers, and Endothelial Progenitor Cells for Predicting Vascular Aging and Diagnosing/Prognosing Age-Related Degenerative Arterial Diseases 155
A promising therapeutic peptide and preventive/diagnostic biomarker for age-related diseases: The Elabela/Apela/Toddler peptide 149
Pathophysiological implications of inflammation and genetic inflammatory factors in hypertensive and old patients affected by sporadic thoracic aortic aneurysm 147
TGF-B pathway polymorphisms as markers for gender differential susceptibility to sporadic thoracic aortic aneurysm 145
Stem cells and new intervention measures as emerging therapy in cardiac surgery 145
Immunohistochemical expression and apoptotic role of Caspase9 in aortic aneurysms 141
Notch 1 pathway and EPCs in bicuspid aortic valve: is their interplay involved in the ascending aortic aneurysm onset? 141
valve prosthesis-patient mismatch: hemodynamic, echocardiografic and clinical evidences 139
Hydrodynamic Alterations Produced by Subaortic Membranes: An in Vitro Study 124
A Narrative Review: Syndecans in Aortic Aneurysm Pathogenesis and Course—Biomarkers and Targets? 123
RED BLOOD CELL DISTRIBUTION WIDTH PREDICTS MORBIDITY AND MORTALITY AFTER AORTIC VALVE REPLACEMENT 121
Matrix Metalloproteinases (MMPs), Their Genetic Variants and miRNA in Mitral Valve Diseases: Potential Biomarker Tools and Targets for Personalized Treatments 115
Retention of temporary epicardial pacing wires: when migration causes dehiscence of a sternal wound 114
Type 5 phosphodiesterase (PDE5) and the vascular tree: From embryogenesis to aging and disease 111
Acute type A aortic dissection: Beyond the diameter 108
Acute Myocardial Infarction Ten Days after Bentall Procedure due to Coronary Embolism: Etiology Discussion and Rare Case Presentation 106
Genotyping strategy of SMAD-3 rs3825977 gene variant for a differential management of ascending aorta aneurysm in women people: Gender oriented diagnostic tools 102
Oxidative Stress in the Pathogenesis of Aorta Diseases as a Source of Potential Biomarkers and Therapeutic Targets, with a Particular Focus on Ascending Aorta Aneurysms 102
Medial tunica degeneration of the ascending aortic wall is associated with specific microRNA changes in bicuspid aortic valve disease 102
Role of the inducibile nitric oxide synthase in inflammatory pathogenesis of the ascending aortic aneurysm 101
Surgical "elephant trunk" arch replacement with a branched arch prosthesis: two alternative operative techniques 99
Polymorphisms of pro-inflammatory IL-6 and IL-1β cytokines in ascending aortic aneurysms as genetic modifiers and predictive and prognostic biomarkers 99
Risk of aortic dissection in patients with ascending aorta aneurysm: a new biological, morphological, and biomechanical network behind the aortic diameter 98
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement 96
The Endothelial Transcription Factor ERG Mediates a Differential Role in the Aneurysmatic Ascending Aorta with Bicuspid or Tricuspid Aorta Valve: A Preliminary Study 96
1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: Results from the Italian OBSERVANT study 96
Advantages of minimal access versus conventional aortic valve replacement in elderly or severely obese patients 95
Corrigendum to “CAR, mGPS and hs-mGPS: Which of these is the best gero-biomarker for age-related diseases? And for what clinical application?” [Mech. Aging Dev. 220 (2024) 111952] 94
Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: results of the multicenter Italian OBSERVANT Registry 93
The effect of preoperative respiratory physiotherapy and motor exercise in patients undergoing elective cardiac surgery: Short-term results 93
CAR, mGPS and hs-mGPS: What is among them the best gero-biomarker for age-related diseases? And for what clinical application? 92
Mitral Valve Surgery by Means of Minimally Invasive Right Mini-Thoracotomy Compared with Standard Sternotomy: Technical Surgical Aspects, Clinical Results in the Current Era 89
Pulmonary artery aneurysm: case report and experience of our center 88
Valve-in-Valve Transcatheter Aortic Valve Implantation Versus Redo SAVR for Degenerated Biological Prosthesis: A Narrative Review Stating Our Experience 88
Imaging and monitoring in minimally invasive valve surgery using an intra-aortic occlusion device: A single center experience 87
A rare localization of papillary fibroelastoma 85
miRNA-Driven Regulation of Endothelial-to-Mesenchymal Transition Differs among Thoracic Aortic Aneurysms 85
A mathematical model to evaluate hemodynamic effects of the graft anastomosis in coronary surgery 83
Casistica 83
miRNA Regulation of Cell Phenotype and Parietal Remodeling in Atherosclerotic and Non-Atherosclerotic Aortic Aneurysms: Differences and Similarities 82
The impact of dual antiplatelet therapy administration on the risk of bleeding complications during coronary artery bypass surgery 82
Alternative surgical approach to repairing a giant sinus of valsalva aneurysm 82
Clinical outcome and hemodynamic performance of st. Jude trifecta aortic prosthesis: Short-term follow-up and risk factors analysis 80
Coronary artery bypass grafting on clopidogrel or ticagrelor therapy: interval of discontinuation and risk of bleeding 80
Bentall Operation: Early Surgical Results, Seven-Year Outcomes, and Risk Factors Analysis 80
Aspetti istomorfologici e genetici degli aneurismi 80
The endoclamp device as a useful strategy during redo surgery on the aortic root and arch 80
[Surgical and percutaneous treatment of hypertrophic obstructive cardiomyopathy: state-of-the-art review] 79
Analysis of the ice front propagation in heart tissues: First results 78
Sutureless Aortic Prosthesis Valves versus Transcatheter Aortic Valve Implantation in Intermediate Risk Patients with Severe Aortic Stenosis: A Literature Review 77
CRT-723 Is the Sporadic Thoracic Aortic Aneurysm the Result of an Inflammatory Process? 76
Biomarkers in Heart Failure: A Review and a Wish 76
Red blood cell distribution width predicts mortality after coronary artery bypass grafting 75
How Refined Surgical Technical Solutions Can Make Bentall Operation a Low-Risk Procedure: 20-Year Personal Experience at the “Root” of the Aortic Diseases—It Is Time to Change Surgical Guidelines 74
Anaortic off-pump coronary artery surgery as a primary strategy to reduce the risk of neurological complications 73
Marfan syndrome in children: correlation between musculoskeletal features and cardiac Z-score 73
Five-Year Outcomes of Transfemoral Transcatheter Aortic Valve Replacement or Surgical Aortic Valve Replacement in a Real World Population: Final Results from the OBSERVANT Study 71
Initial Surgical Strategy for the Treatment of Type A Acute Aortic Dissection: Does Proximal or Distal Extension of the Aortic Resection Influence the Outcomes? 71
The benefit of a preoperative respiratory protocol and musculoskeletal exercise in patients undergoing cardiac surgery 71
miR-632 Induces DNAJB6 Inhibition Stimulating Endothelial-to-Mesenchymal Transition and Fibrosis in Marfan Syndrome Aortopathy 71
Warm blood versus St. Thomas cardioplegia for myocardial protection in patients undergoing coronary artery bypass grafting 70
Numerical simulations of temperature inside the heart tissues to evaluate the performances of cryoablative probe 69
The need for the STS Score risk stratification system for aortic root aneurysms surgery 69
Retinal and Choroidal Vasculature in Patients with Marfan Syndrome 68
Totale 13.619
Categoria #
all - tutte 60.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.641


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022655 44 114 32 19 24 33 36 45 82 65 39 122
2022/2023940 105 162 28 104 96 143 60 78 106 1 47 10
2023/20241.063 19 57 12 34 27 70 34 89 5 400 202 114
2024/20252.431 93 273 214 177 76 84 151 116 212 228 288 519
2025/20267.587 525 209 648 564 592 989 1.165 778 621 625 419 452
2026/2027223 223 0 0 0 0 0 0 0 0 0 0 0
Totale 16.111